Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × cT2a N0NxM0 Renal Tumor × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 31 Kidney Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Carcinoma, Hepatocellular 5 Colorectal Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Glioblastoma 3 Carcinoma 3 Thyroid Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Liver Neoplasms 2 Endometrial Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 cT2a N0NxM0 Renal Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Relapsed Pediatric Solid Tumor 1 Radiation Therapy 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02597322 2025-04-06

AXIPAN

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

cT2a N0NxM0 Renal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡